Clinical Trial Update: to Assess the Accuracy and Reliability of the Ga68-Dolacga Positron Emission Tomography Compared to Computer Tomography Volumetry and Indocyanine Green Retention Test for Measurement of Liver Reserve [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing Ga68-Dolacga PET versus CT volumetry and ICG retention for measuring liver reserve in hepatic carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Carcinoma

Drugs mentioned

• Ga68-Dolacga (Ga68-Dolacga)

Snippet

Sponsor: National Atomic Research Institute, Taiwan | Conditions: Hepatic Carcinoma | Phase 2 | Status: COMPLETED